10.45% 0.0428

Medicus Pharma Ltd (MDCX)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Medicus Pharma Ltd Stock (MDCX) Company Profile

Medicus Pharma Ltd

Healthcare (1115)

610-540-7515

300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MDCX's Discussions on Twitter

Compare MDCX vs LLY, JNJ, ABBV, AZN, MRK

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MDCX Medicus Pharma Ltd	0.4455	12.09M	0	-27.04M	-17.53M	-1.9743
LLY Lilly Eli Co	920.31	792.08B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	244.25	584.06B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	217.69	376.96B	61.16B	4.19B	17.82B	2.3614
AZN Astrazeneca Plc	196.19	300.68B	58.80B	10.24B	8.98B	3.2788
MRK Merck Co Inc	120.13	291.99B	64.93B	18.26B	12.36B	7.2751

Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten

Finanzdaten der Medicus Pharma Ltd-Aktie (MDCX)

Medicus Pharma Ltd-Aktie (MDCX) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
VELOCITY FUND PARTNERS, LP	10% Owner	May 20 '25	Sale	7.72	75,000	578,940	3,248,741

Medicus Pharma Ltd (MDCX)

Medicus Pharma Ltd Stock (MDCX) Company Profile

Compare MDCX vs LLY, JNJ, ABBV, AZN, MRK

Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten

Ideas Watch: Is Medicus Pharma Ltd Equity Warrant likely to announce a buybackQuarterly Portfolio Summary & Accurate Trade Setup Notifications - baoquankhu1.vn

Medicus Pharma on Bloomberg World - Burlington Free Press

Small cap wrap: Namibia Critical Metals, Medicus Pharma, Greatland Resources... - Proactive financial news

Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate - TipRanks

Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2 - TipRanks

D. Boral Capital cuts Medicus Pharma stock price target on dilution concerns - Investing.com Canada

Medicus Pharma highlights independent support for Phase 2 SkinJect results - Yahoo! Finance Canada

Medicus Pharma Ltd Reports KOL Validation of Skinject Phase 2 Data of 80% Overall Response Rate - marketscreener.com

Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate - Caledonian Record

Medicus study suggests 3 of 4 skin cancer lesions may clear without immediate surgery - Stock Titan

[EFFECT] Medicus Pharma Ltd. SEC Filing - stocktitan.net

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Las Cruces Sun-News

Bull Bear: Is Medicus Pharma Ltd Equity Warrant stock forming a cup and handleMarket Risk Report & Momentum Based Trading Ideas - baoquankhu1.vn

Free cash flow per share of Medicus Pharma Ltd. – NASDAQ:MDCXW - TradingView

Medicus Pharma (MDCX): A Small-Cap Biotech Making Moves in 2026 - openPR.com

MDCXW Financials: Income Statement, Balance Sheet & Cash Flow - stocktitan.net

Medicus Pharma to host business update call featuring clinical investigator - MSN

Medicus Pharma reports 80% response rate in skin cancer study By Investing.com - Investing.com Canada

Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan - TipRanks

Medicus Pharma advances SkinJect, Teverelix programs, eyes catalyst-rich 2026 - Yahoo Finance

Medicus Pharma reports 80% response rate in skin cancer study - Investing.com

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan - The Manila Times

Three in four lesions cleared in Medicus skin cancer study at Day 57 - stocktitan.net

Momentum Shift: Is Medicus Pharma Ltd Equity Warrant a potential multi baggerPortfolio Update Report & Stock Market Timing Techniques - baoquankhu1.vn

Medicus Biosciences—Biotech Company Focused on Innovative Microneedle Technology and Global Patent Portfolio - Minichart

Medicus Pharma Advances SkinJect and Teverelix Pipelines, Adds AI to Clinical Strategy - TipRanks

MDCX SEC FilingsMedicus Pharma Ltd 10-K, 10-Q, 8-K Forms - Stock Titan

Medicus Pharma Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Medicus Pharma (MDCX) registers 7.5M shares; Phase 2 D‑MNA topline noted - Stock Titan

Medicus Pharma (NASDAQ: MDCX) registers 3.245M common shares from warrants - Stock Titan

Medicus Pharma (MDCX) 1.12M shares issuable on warrants — prospectus supplement - Stock Titan

Medicus Pharma (MDCX) registers 2.26M shares tied to public warrants - Stock Titan

1.397M resale shares registered as Medicus Pharma (NASDAQ: MDCX) shifts S-1 to S-3 - stocktitan.net

[POS AM] Medicus Pharma Ltd. SEC Filing - stocktitan.net

Medicus Pharma (MDCX) files prospectus supplement registering 1.397M shares - Stock Titan

Medicus Pharma (NASDAQ: MDCX) outlines SkinJect and Teverelix clinical plans - stocktitan.net

Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update - ACCESS Newswire

Biotech says 3 in 4 patients may avoid immediate skin cancer surgery - stocktitan.net

Medicus Pharma 2025 10-K: Net loss $35.4M, EPS $(2.74) - TradingView

MDCX Stock Price, Quote & Chart | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill

Medicus Pharma to Host Business Update Call Featuring Clinical Investigator - MyChesCo

Medicus Pharma Ltd.Common Stock (NQ: MDCX - The Chronicle-Journal

Medicus Pharma reports phase 2 results for basal cell carcinoma therapy - MSN

Medicus Pharma stock swings after skin cancer treatment results - msn.com

EBITDA per share of Medicus Pharma Ltd. – NASDAQ:MDCXW - TradingView

Tangible book value per share of Medicus Pharma Ltd. – NASDAQ:MDCXW - TradingView

Book value per share of Medicus Pharma Ltd. – NASDAQ:MDCXW - TradingView

Working capital per share of Medicus Pharma Ltd. – NASDAQ:MDCXW - TradingView

Revenue per share of Medicus Pharma Ltd. – NASDAQ:MDCXW - TradingView

Whats next for Medicus Pharma Ltd Equity Warrant stock2026 Technical Overview & Precise Swing Trade Alerts - baoquankhu1.vn

Medicus reports phase 2 results for SkinJect basal cell carcinoma study - MSN

Finanzdaten der Medicus Pharma Ltd-Aktie (MDCX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Medicus Pharma Ltd-Aktie (MDCX) Insiderhandel

Ähnlich wie MDCX